EUVIMEDEUVIMED entdecken
Studienprotokoll

Early First-Line Bortezomib for Acute Antibody-Mediated Rejection: A Retrospective Review of Long-Term Outcomes From a Uniform Single-Center Protocol

Keren Tzukert, Roy Abel, Gil Benedek, Galina Pizov, Ashraf Imam, Abed Khalaileh, Michal Dranitzki Elhalel

Transplantation Proceedings · 2026

DOI: 10.1016/j.transproceed.2026.07.032 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Keren Tzukert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: Kerentz@ha…. Hauptthemen laut MEDLINE: Bortezomib, Graft Rejection, Kidney Transplantation, Pyrazines. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BortezomibGraft RejectionKidney TransplantationPyrazinesBoronic AcidsImmunosuppressive AgentsHumansRetrospective StudiesFemaleMiddle AgedMaleTreatment OutcomeAdultTime FactorsAcute DiseaseGraft Survival

Substanzen

BortezomibPyrazinesBoronic AcidsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Nephrology and Hypertension, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: Kerentz@hadassah.org.il.
  • Department of Nephrology and Hypertension, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Tissue Typing and Immunogenetics Unit, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Department of Pathology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Transplantation Unit, General Surgery Department, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.

Zitieren

APA

Tzukert, K., Abel, R., Benedek, G., Pizov, G., Imam, A., Khalaileh, A., & Elhalel, M. D. (2026). Early First-Line Bortezomib for Acute Antibody-Mediated Rejection: A Retrospective Review of Long-Term Outcomes From a Uniform Single-Center Protocol. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.07.032

Vancouver

Tzukert K, Abel R, Benedek G, Pizov G, Imam A, Khalaileh A, et al. Early First-Line Bortezomib for Acute Antibody-Mediated Rejection: A Retrospective Review of Long-Term Outcomes From a Uniform Single-Center Protocol. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.07.032

BibTeX
@article{Tzukert2026,
  author = {Tzukert, Keren and Abel, Roy and Benedek, Gil and Pizov, Galina and Imam, Ashraf and Khalaileh, Abed and Elhalel, Michal Dranitzki},
  title = {Early First-Line Bortezomib for Acute Antibody-Mediated Rejection: A Retrospective Review of Long-Term Outcomes From a Uniform Single-Center Protocol},
  journal = {Transplantation Proceedings},
  year = {2026},
  doi = {10.1016/j.transproceed.2026.07.032}
}
Kostenlos starten →